According to reports, some 2,400 innocent monkeys have thus far been infected with the deadly strain of coronavirus, which the European Centre for Disease Prevention and Control estimates has killed nearly 1,000 people. But scientists say it's already led to success in the form of an experimental antiviral vaccine called remdesivir.
Remdesivir, they say, has been shown to be beneficial in treating Middle East respiratory syndrome, or MERS, which is a type of coronavirus similar to SARS (severe acute respiratory syndrome) and the more recent Wuhan coronavirus (CoVid-19).
MERS, in case you're unfamiliar with it, can cause fever, cough, and/or shortness of breath, much like the Wuhan coronavirus. It also leads to pneumonia, in many cases, as well as organ failure or septic shock. Furthermore, about 35 percent of those who contract it end up dying.
All of these symptoms are closely related to what becomes of many of the people who contract the Wuhan coronavirus (CoVid-19), which is why scientists are hoping that remdesivir might be successful in treating it.
Since the National Institutes of Health (NIH) says that remdesivir helped macaque monkeys overcome MERS, the idea is that it might similarly be helpful in combating the Wuhan coronavirus (CoVid-19), seeing as how they're both within the same family of viruses.
Listen below as Mike Adams, the Health Ranger, unpacks evidence suggesting that the Wuhan coronavirus (CoVid-19) is a biological weapon that was either accidentally or intentionally released from a bioweapons laboratory:
Other scientists are busy testing remdesivir as well
In other parts of China, there are believed to be similar tests taking place with remdesivir which, by all appearances, is more than likely going to be the drug of choice that the establishment carts out as a "cure" for the Wuhan coronavirus (CoVid-19).
The results of one such study have already been published in a journal called Drug Target Review, and they detail a group of monkeys being housed in Hamilton, Montana, that received remdesivir 24 hours before being deliberately infected with MERS-CoV.
Another group of monkeys was given the vaccine about 12 hours before receiving the same infection, while another control group was infected with the virus without any treatment. Six days later, those monkeys that were treated in advance of becoming infected with the virus showed no symptoms of the disease.
Those treated after being infected still reportedly fared better than those receiving no treatment at all, as they showed less damage to their lungs compared to the control animals.
"MERS-CoV" is closely related to the 2019 novel coronavirus (2019-nCoV) that has grown to be a global public health emergency since cases were first detected in Wuhan, China, in December," reads a statement issued by the NIH.
"Remdesivir has previously protected animals against a variety of viruses in lab experiments. The drug has been shown experimentally to effectively treat monkeys infected with Ebola and Nipah viruses."
The statement goes on to explain that the results of this latest study are "promising" and support further clinical trials into the use of remdesivir for both MERS-CoV and 2019-nCoV (the latter of which has since been renamed as CoVid-19).
Drug testing on animals, and particularly monkeys, is sadly quite common. In the United Kingdom, for instance, it is estimated that about 3,000 monkeys are used annually to test new drugs and vaccines for the conventional medicine industry.
Be sure to check out Pandemic.news for more breaking news about the Wuhan coronavirus (CoVid-19).
Sources for this article include:
Please contact us for more information.
